Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• \- Patients with a clinical diagnosis of keloids Able to obtain informed consent
Locations
Other Locations
China
Peking Union Medical College Hospital
RECRUITING
Beijing
Contact Information
Primary
Zhaohui Zhu, MD
13611093752@163.com
13611093752
Backup
Jiarou Wang, MD
ChristinaWang97@163.com
13628477019
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2027-10
Participants
Target number of participants: 30
Treatments
Experimental: 68Ga-RGD PET/CT
All patients diagnosed with keloid underwent 68Ga-RGD PET/CT.
Related Therapeutic Areas
Sponsors
Leads: Peking Union Medical College Hospital